Zimbabwe has rejected a substantial American healthcare agreement worth 367 million US dollars (£272m) spanning five years because of Washington's insistence on confidential information.
This move came to light after a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the deal was "skewed".
A government representative has since stated that the United States was demanding access to biological samples for scientific study and profit but was not willing to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has appealed for continued dialogue to secure a agreement agreeable to all parties so the nation's vital HIV programme can continue.
Wider Background
Zimbabwe's decision comes after a similar situation in Kenya, where a high court suspended a related deal with the US following concerns were raised about the safety of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government agreements to boost transparency and responsibility.
Based on statements, Sixteen African countries have to date agreed to these new agreements, representing more than $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this partnership might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, without any corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"Effectively, our country would supply the raw materials for scientific discovery with no assurance that the resulting innovations would be accessible to our people if a new disease outbreak emerge."
National Interest and Global Health
Mangwana further pointed out that the American exit from the global health body and its push of one-on-one health agreements were undermining frameworks previously set up via the international health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to manage potential global health emergencies.
"This system is intended to guarantee that when a nation provides its samples, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," he added.
"We welcome ongoing dialogue with our US partners on how subsequent co-operation could be designed in a manner that respects the independence and dignity of each country."
Medical Community Reaction
A leading public health body said it understood the government's concerns, but recommended that negotiations must proceed since much of the nation's HIV programmes were funded by international support.
"In cases where specific concerns exist, such as those relating to information security or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," it added.
The halted deal highlights the continuing challenges between accepting vital foreign assistance and protecting local interests in an increasingly interconnected world.